up and coming crypto 2021 snippets

Wentai Technology: Shareholders plan to reduce their holdings by no more than 2%;Many of them announced their reduction in the evening, except for the 11-board Yiming food, others also included.Second, Contemporary Amperex Technology Co., Limited's enlargement trick: special dividends for factories in Europe

Let's talk about some encouraging and unintelligent observations. Now the main purpose of everyone's smashing is to adjust positions, not to sell them back. This is the biggest difference from the past few years! Explain that regardless of retail investors, institutions and foreign investors, they still believe in the A-share bull market.True Vision: The controlling shareholder and others intend to reduce their holdings by 4% in total;Contemporary Amperex Technology Co., Limited, as the king of volume, stopped making money everywhere and began to repay investors! Other domestic new energy giants can learn from it. Yesterday, Ning Wang opened higher and lower, and took the GEM with a bias. In the evening, the two big benefits were blessed. Can today's surge drive the GEM to rise?

In short, it is the recent big bull stocks that have been announced to reduce their holdings. For example, Yiming Food has 11 consecutive boards, and the price of the world has reached a record high. Zhongyan shares have two 20cm daily limit! They are all popular topics such as AI applications and robots. Many have indeed risen a lot, even to record highs, but the reason is to rub a hot spot. In this case, it is normal for shareholders to reduce their holdings! The human heart is like this, and you can't stop it.However, it is a great pity that the China stock market has never had a history of retail investors and institutions getting rich together. Don't deal with hot money and quantification! Foreign investment in A-shares has also become stale and has become fond of speculation. There are always too many routines to create A shares, which is too tiring to play, and the experience is really bad.Among them, the biggest benefit is the biomedical industry. It is necessary to set up a M&A fund with a scale of 10 billion, which is specifically aimed at the merger and reorganization of the biomedical industry! The focus is on local enterprises in Shanghai, especially the biomedicine of listed companies in Shanghai.